Bevacizumab, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer

NCT00052559 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

NIH

Sponsor class

Conditions

Adenocarcinoma of the Rectum
Stage II Rectal Cancer
Stage III Rectal Cancer

Interventions

BIOLOGICAL: bevacizumab
DRUG: fluorouracil
RADIATION: external beam radiation therapy
PROCEDURE: therapeutic conventional surgery
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)